Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
about
Erythropoietin in the general population: reference ranges and clinical, biochemical and genetic correlatesFactor XIII activity mediates red blood cell retention in venous thrombi.A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection.Risk management of biosimilars in oncology: each medicine is a work in progress.Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients.Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare studyAnemia associated with chronic heart failure: current concepts.Recombinant human epoetin beta in the treatment of chemotherapy-related anemia.Fibrinogen and red blood cells in venous thrombosis.Anemia in heart failure: an overview of current concepts.Anemia in chronic heart failure: can we treat? What to treat?Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice.Diagnosis of anaemia: old things rearranged.Diagnosis and treatment of cancer-related anemia.Erythropoietin-stimulating agents and clinical outcomes in metastatic breast cancer patients with chemotherapy-induced anemia: a closed debate?Fibrinogen, red blood cells, and factor XIII in venous thrombosis.Drug-Induced Thrombophilic or Prothrombotic States.Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury.Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loaded nanostructured lipid carriers.Mesenteric infarction due to iatrogenic polycythemia.Critical Role of Iron in Epoetin Alfa Treatment of Chemotherapy-Associated Anemia.Neuroprotection with an erythropoietin mimetic peptide (pHBSP) in a model of mild traumatic brain injury complicated by hemorrhagic shock.Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the Netherlands.Red blood cells in thrombosis.Is there a role for intravenous iron therapy in patients undergoing colorectal cancer resection?
P2860
Q28546759-EED342B3-A7C5-4C21-9AB8-555019A4BEF0Q33944224-994B8BBD-A5D6-40D1-B437-83ECEB81DD89Q35745446-F08224EB-EB63-4E0A-973B-34EF3492695DQ35795287-1ACCB1F9-ED7D-407A-ACD2-A6749F7BD8ECQ35851384-F0DD3E49-4CC6-4070-9039-7B0861897221Q36251046-A08D06C3-67F1-4E2A-A5B3-D79A85D536CFQ36600453-FFFC04B8-11C1-46E8-B3A0-09AF62AC99DCQ37230276-673DBA3E-CD01-466F-A0A5-857D5E73234BQ37730948-43179CF4-E0A8-4570-9E64-74AF839A5D27Q37822727-AA3D1B19-D00B-4EAB-8A55-A3827F486D1DQ37943240-E3B58B04-92C9-4579-8E42-EB9FC86A86FAQ37991783-6285AE63-2BA2-45A1-AA4D-63A23BC154DFQ38058415-CF4B9E07-2CCB-4FAC-B401-7B4C8BB5C761Q38188501-7B378B16-C977-4953-9080-C81FB69F2A8AQ38189738-4CC6E424-91DD-436D-AA9A-4796FE4E2FE8Q38543294-34BF51DC-CEFF-4F36-8A02-0ADC8163D6F2Q38853241-154E1B53-F93D-4A80-B98E-57F90D9E1662Q39948879-65FA4FBE-B388-48D4-A8C0-618C11B05079Q41853076-615103C4-FFD4-4960-A6DB-E262E5756B89Q41855598-281B31BF-3867-40DE-94D2-D19301AA0A20Q42336239-0FEB1C4C-80B3-4569-86FE-3682E177F968Q42409549-AD2BB2EC-CE29-499D-BB7E-1B7CC5B644EFQ43796802-6B5A3099-94F4-48F9-B23F-01B9490882B6Q48003288-5CA6431E-3705-47E4-9E93-C8B659A6E271Q50498722-530309C2-A4D5-484E-AE48-0571EC0656DA
P2860
Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
@en
Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
@nl
type
label
Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
@en
Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
@nl
prefLabel
Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
@en
Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
@nl
P1433
P1476
Venous thromboembolic events and erythropoiesis-stimulating agents: an update.
@en
P2093
Mario Dicato
P356
10.1634/THEONCOLOGIST.13-S3-11
P478
13 Suppl 3
P577
2008-01-01T00:00:00Z